DRUG GUIDELINE

Protamine
SCOPE (Area): Emergency, Operating Suite, ICU, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), Cardiovascular Suite, (Exclude: Coronary Care Unit)
SCOPE (Staff): Medical, Nursing, Pharmacy
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice) and all other Wards


Preamble

See Appendix 1 for full version of this Drug Guideline!


Related Documents

CPP0097 - Massive Transfusion
DRG0038 - Heparin
CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPP0544 - Intravenous Drug Administration And Classification List
POL0077 - Medication Management
CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
SOP0001 - Principles Of Clinical Care


References

Alfred Health (2019, April). Therapeutic Anticoagulation wit Unfractionated Heparin. Alfred Health. Retrieved April 2019 from personal communication.
Barwon Health (2018, March). Protamine Drug Protocol. Barwon Health. Retrieved February, 2019 from personal communication.
CRC Press Taylor & Francis Group. (2019). Renal Drug Database. Retrieved April 28, 2019 from
MIMS Online. (2019, April). MIMS Online, Protamine Sulfate Injection BP product information. Retrieved April 22, 2019 from
Rossi, S. (2019, January). Australian Medicines Handbook. Retrieved April 22, 2019, from
The Society of Hospital Pharmacists of Australia. 2019. Australian Injectable Drugs Handbook (7th ed.). Retrieved April 22, 2019, from
Walters Kluwer. (2019). UpToDate, Drug Interaction section. Retrieved April 22, 2019, from


Appendix

Appendix 1 - Protamine



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 01/10/2020
Review Responsibility: Pharmacist - Rotational Date for Review: 30/09/2024
Protamine - DRG0030 - Version: 5 - (Generated On: 19-06-2025 05:50)